About RemedyBio
RemedyBio is a company based in Dublin (Ireland) founded in 2017. RemedyBio has raised $9.43 million across 4 funding rounds from investors including Enterprise Ireland, European Union and Dublin City University. RemedyBio offers products and services including Therapeutic Discovery Platform and Immune System Mapping Tool. RemedyBio operates in a competitive market with competitors including Annexon, Syndax, Abingdon Health, Clovis Oncology and Spear Bio, among others.
- Headquarter Dublin, Ireland
- SectorsHealthcare
- Email••••••••
- Website remedybiologics.com
- Social LinkedIn X
- Total Equity Funding$9.43M (USD)
in 4 rounds
- Latest Funding Round$22.91K (USD), Grant
Jun 2022
- InvestorsEnterprise Ireland
& 4 more
Products & Services of RemedyBio
RemedyBio offers a comprehensive portfolio of products and services, including Therapeutic Discovery Platform and Immune System Mapping Tool.
Platform for mapping cell functions to discover new immune therapies.
Tool that analyzes patient biology for therapeutic development.
Funding Insights of RemedyBio
RemedyBio has successfully raised a total of $9.43M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $22.91 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.43M
- Total Rounds 4
- Last Round Grant — $22,914
- First Round $2.82M
(Jun 2020)
- Investors Count 5
All 4 funding rounds of RemedyBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $22,914 | Grant | – | – | |
| Jul 2021 | $9.43M | Series A | – | – | |
| Sep 2020 | $2.98M | Grant | – | – | |
| Jun 2020 | $2.82M | Grant | – | – |
5 investors in total: 5 institutional.
Investors in RemedyBio
RemedyBio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Enterprise Ireland, European Union and Dublin City University.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Support is provided to Irish manufacturing and service sector businesses. | 1998 | enterprise-ireland.com | Dublin, Ireland | |
Foundation fund focused on science & technology in Ireland | 2000 | sfi.ie | Dublin, Ireland | |
Dublin City University is recognized as a leading educational institution. | 1975 | dcu.ie | Dublin, Ireland |
Investor details for RemedyBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of RemedyBio
3 dated milestones of RemedyBio across 5 years, from founding to its latest funding, stage changes and deals.
- Founded RemedyBio is founded.
- Funding First funding round of $2.8M.
- Funding Latest funding round, Grant, of $23K.
Competitors of RemedyBio
RemedyBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Syndax, Abingdon Health, Clovis Oncology and Spear Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| annexonbio.com | 2011 | San Francisco, United States | $256M | 80 | Developer of antibodies to treat complement-mediated neurodegenerative diseases | |
| syndax.com | 2005 | Waltham, United States | $198.29M | 107 | Targeted therapies for cancer treatment are developed. | |
| abingdonhealth.com | 2008 | York, United Kingdom | $24.05M | 151 | Developer of immunoassays for diagnostic purposes | |
| clovisoncology.com | 2009 | Boulder, United States | $423.26M | 280 | Develops innovative immunotherapy drugs for cancer treatment. | |
| spear.bio | 2021 | Boston, United States | $48.96M | – | Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers | |
| aurontx.com | 2018 | Wellesley, United States | $103.84M | – | Developer of cancer therapeutics for the treatment of blood cancer | |
| olink.com | 2004 | Uppsala, Sweden | – | 138 | Provider of products and services for human protein biomarker research and development |
Detailed competitors of RemedyBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Remedybio
Complete news archive for RemedyBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to RemedyBio
10 companies that operate in the same segment as RemedyBio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RemedyBio
RemedyBio was founded in 2017 and raised its 1st funding round 3 years after it was founded.
RemedyBio is headquartered in Dublin, Ireland.
RemedyBio is a funded company, having raised a total of $9.43M across 4 funding rounds to date. The company's 1st funding round was a Grant of $2.82M, raised on Jun 2020.
RemedyBio was founded in 2017 in Dublin, Ireland, within the biotechnology sector. Personalized, cell-based, and autologous therapies targeting tumors are developed and offered. Nanoscale biotechnology is employed for diagnostic purposes in immunoncology, autoimmune diseases, and infectious conditions. Individual cell functions are analyzed across 10 million to 1 billion living cells to support therapeutic design and evaluation.
RemedyBio's top competitors include Syndax, Annexon and Abingdon Health.
RemedyBio offers Therapeutic Discovery Platform and Immune System Mapping Tool.
RemedyBio has 5 investors. Key investors include Enterprise Ireland, European Union, Dublin City University, Science Foundation Ireland, and EIC Fund.